Rosenblatt Maintains Buy on Nutanix, Raises Price Target to $75

Benzinga · 2d ago
Rosenblatt analyst Blair Abernethy maintains Nutanix (NASDAQ:NTNX) with a Buy and raises the price target from $60 to $75.